Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak

Filippi, Andrea Riccardo; Russi, Elvio; Magrini, Stefano Maria; Corvò, Renzo

doi:10.1016/j.ijrobp.2020.03.007

Cited by 124 publications

(113 citation statements)

References 3 publications

Supporting

Mentioning

101

Contrasting

Unclassified

Order By: Relevance

“…However, because the number of infected patients whose route of infection was unknown increased, our Prime Minister finally declared a state of emergency on 9 April. Several organizations or radiotherapy departments from severely affected regions published emergency guidelines or suggested solutions for the management of cancer patients during the global COVID-19 pandemic [2][3][4][5][6][7][8][9].…”

Section: Introductionmentioning

confidence: 99%

Preparation for the COVID-19 pandemic in the department of radiation oncology in the National Cancer Center Hospital in Tokyo

Murakami

Igaki

Okamoto

et al. 2020

Journal of Radiation Research

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Preparation for the COVID-19 pandemic in the department of radiation oncology in the National Cancer Center Hospital in Tokyo

Murakami

Igaki

Okamoto

et al. 2020

Journal of Radiation Research

View full text Add to dashboard Cite

“…An algorithm was also proposed by a northern Italian group of radiation oncology that insisted on continuing to deliver treatment for cancer patients with adoption of hypo fractionated protocols whenever possible, while withholding radiotherapy for benign disease or postponing it if possible, in the adjuvant setting, and withholding treatment only for confirmed or highly suspicious cases of COVID-19 (76).…”

Section: The Italian Experiencementioning

confidence: 99%

Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

Moujaess

Kourié

Ghosn

2020

Critical Reviews in Oncology/Hematology

200

View full text Add to dashboard Cite

The novel coronavirus, also known as SARS-Cov-2 or COVID-19 has become a worldwide threat and the major healthcare concern of the year 2020. Cancer research was directly affected by the emerging of this disease. According to some Chinese studies, cancer patients are more vulnerable to COVID-19 complications. This observation led many oncologists to change their daily practice in cancer care, without solid evidence and recommendations. Moreover, the COVID-19 manifestations as well as its diagnosis are particular in this special population. In this review paper we expose the challenges of cancer management in the era of SARS-CoV-2, the epidemiological, clinical, pathological and radiological characteristics of the disease in cancer patients and its outcomes on this population. Finally, we focus on strategies that are followed in cancer management with review of national and international guidelines. J o u r n a l P r e -p r o o f electronic search of the literature was conducted in the PubMed database until the 5th of April 2020. The following keywords with Boolean operators were used 'covid-19', 'novel coronavirus'and 'SARS-CoV-2' in combination with 'cancer', 'neoplasm', 'oncology' and 'malignancy'. A total of 223 articles were extracted. We included articles in English as well as articles in French because we are familiar with this language. Abstracts in English of articles in Chinese language were also J o u r n a l P r e -p r o o f 3 included. Duplicated articles and articles that were published before the era of SARS-Cov-2 (i.e., before December 2019) were excluded. Titles and abstracts of retrieved articles were screened for eligibility, and then entire texts were analyzed and 88 papers that respond to our objectives were included in this review. Our work is summarized in the PRISMA diagram below. ResultsOut of 88 articles, six were in French language and 19 were in Chinese language with English abstracts. Most of the papers consisted of short editorials, letters, correspondence or comments.Ten Cohort studies were identified (retrospective, prospective or cross-sectional analysis) as well as 9 case reports and one case series. Only four of the cohort studies exclusively included cancer patients. Of note, all cohort studies were conducted in China. Most of the reported cases originated from China and Italy.59% of the published papers originated from China and Italy (52 of 88). Seven works were multinational and the majority of them were multicontinental, issued in collaboration between researchers from Asia, Europe and the Americas. We identified one article originating from each of the following countries: Canada, India, Singapore, Spain and Saudi Arabia. The pie chart below

show abstract

“…En cas d'évolution clinique favorable, l'oncologue radiothérapeute valide la reprise du traitement après la semaine d'arrêt, si les symptômes ont disparu depuis au moins 48 h (10). Les séances sont décalées en fin de programme et le port d'un masque chirurgical est imposé dès l'entrée dans le service.…”

Section: Détection Des Patients Suspects De Contamination Par Le Sarsunclassified

Organisation d’un service de radiothérapie pendant l’épidémie de COVID-19 : expérience du centre hospitalier de Mulhouse

Ohnleiter

Piot

Rogenmuser

et al. 2020

Cancer/Radiothérapie

View full text Add to dashboard Cite

L'épidémie de COVID-19 continue de croître de manière exponentielle dans notre pays. Si la majorité des formes sont bénignes, les patients atteints de cancer sont à risque de voir se développer une forme grave de la maladie. Les services de radiothérapie sont un lieu à potentiel de contamination en raison du nombre de patients traités et de personnels présent. Leur organisation pendant la période épidémique vise à assurer la continuité des soins tout en limitant le risque de décès dû à une contamination par le SARS-CoV-2 (virus responsable de la COVID-19). Dans le service de radiothérapie du groupe hospitalier de la région de Mulhouse et Sud-Alsace, cette organisation s'articule en cinq points : la protection des personnels médicaux et paramédicaux, la protection des Page 2 of 11 J o u r n a l P r e -p r o o f 2 patients en cours de traitement, la détection des patients suspects d'être atteints de COVID-19 et leur prise en charge, la réorganisation du circuit patient et les mesures concernant l'organisation du système qualité du service. Nos pistes de réflexion, débutée dès le début de l'épidémie dans notre département, nous permettent de préserver au maximum l'accès aux soins radiothérapiques en anticipant le risque de diffusion du virus. Grâce à des réunions bihebdomadaires, nous continuons à nous adapter à l'évolution épidémique dans notre service, en tenant compte de nos moyens matériels. La possibilité de réaliser des tests de diagnostic chez tous les patients suspects nous permettrait également d'affiner nos procédures. SummaryThe COVID-19 outbreak grows exponentially in our country. Despite most of patients develops benign symptoms, cancer patients are at risk of a severe form of the disease. Radiotherapy centres are a potential contamination place due to the number of patients treated and staff present. Their organization during the outbreak period aims to ensure continuity of care while limiting the risk of death from COVID-19. In the radiotherapy department of Mulhouse hospital (France), we pointed five points out: protection of medical and paramedical staff, protection of patients undergoing treatment, detection of patients suspected of being infected by SARS-CoV-2 and their management, reorganization of the patient circuit and measures regarding the quality management. This reflection, which began at the beginning of the outbreak in our city, allows us to preserve the access to radiotherapy treatments by anticipating the risk of spreading the virus. Through biweekly meetings, we continue to adapt to the epidemic in our department, considering our material resources. The ability to perform diagnostic tests in all suspect patients would also allow us to refine our procedures.

show abstract

Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak

Cited by 124 publications

References 3 publications

Preparation for the COVID-19 pandemic in the department of radiation oncology in the National Cancer Center Hospital in Tokyo

Preparation for the COVID-19 pandemic in the department of radiation oncology in the National Cancer Center Hospital in Tokyo

Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence

Organisation d’un service de radiothérapie pendant l’épidémie de COVID-19 : expérience du centre hospitalier de Mulhouse

Contact Info

Product

Resources

About